P561: Impact of ustekinumab TDM on clinical practice: a multi-centre, prospective, cross-sectional observational trial—mUST-Decide
ECCO '19 Copenhagen
2019
P562: Treatment of older inflammatory bowel disease patients; steroid use and escalation to steroid sparing therapy
ECCO '19 Copenhagen
2019
P563: Thiopurine adverse events in patients with inflammatory bowel disease in the UK: inflammatory bowel disease BioResource cohort
ECCO '19 Copenhagen
2019
P564: Significant reduction of admission time at the IBD infusion unit by an e-health pre-admission assessment and order system for intravenous therapy
ECCO '19 Copenhagen
2019
P565: Infliximab therapy intensification upon loss of response: what should be the cut-off for trough levels?
ECCO '19 Copenhagen
2019
P567: Could an escalation of therapy or intervention (ETI) calculator be used to triage appointments for patients with ulcerative colitis?
ECCO '19 Copenhagen
2019
P568: Bowel ultrasonography is useful to evaluate disease activity in ulcerative colitis patients
ECCO '19 Copenhagen
2019
P569: A national, retrospective, observational study on the use of 5-aminosalicylates (5-ASA) in Crohn’s disease (CD)
ECCO '19 Copenhagen
2019
P570: Kock pouches in the 21st century: a descriptive study of short-term (30-day) outcomes in a national cohort of 177 patients
ECCO '19 Copenhagen
2019
P571: Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study
ECCO '19 Copenhagen
2019
P572: Half of children with acute severe colitis have predominant single faecal bacterial species, mostly Escherichia coli: Microbiome results from the PRASCO trial
ECCO '19 Copenhagen
2019
P573: Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study
ECCO '19 Copenhagen
2019
P574: IBD patients should be stratified to guide out-of-hospital monitoring: ICHOM-derived outcomes from a dedicated IBD telephone clinic
ECCO '19 Copenhagen
2019
P575: Simple novel tacrolimus enemas are very effective in severe refractory proctitis
ECCO '19 Copenhagen
2019
P576: Therapeutic drug monitoring as predictive marker of mucosal healing in Crohn’s disease patients treated with anti-TNF: a prospective multi-centre study
ECCO '19 Copenhagen
2019
P577: Drug Induced Liver Injury (DILI) secondary to biologic therapy in IBD: ECCO- CONFER Series
ECCO '19 Copenhagen
2019
P578: Therapeutic strategies in the approach of paradoxical psoriasis in IBD: experience of a centre
ECCO '19 Copenhagen
2019
P579: Wearable Devices Can Predict Disease Activity in inflammatory bowel disease Patients
ECCO '19 Copenhagen
2019